Exact Mass: 507.3563

Exact Mass Matches: 507.3563

Found 33 metabolites which its exact mass value is equals to given mass value 507.3563, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

Cholylvaline

3-methyl-2-(4-{5,9,16-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl}pentanamido)butanoic acid

C29H49NO6 (507.356)


Cholylvaline belongs to a class of molecules known as bile acid-amino acid conjugates. These are bile acid conjugates that consist of a primary bile acid such as cholic acid, doxycholic acid and chenodeoxycholic acid, conjugated to an amino acid. Cholylvaline consists of the bile acid cholic acid conjugated to the amino acid Valine conjugated at the C24 acyl site.Bile acids play an important role in regulating various physiological systems, such as fat digestion, cholesterol metabolism, vitamin absorption, liver function, and enterohepatic circulation through their combined signaling, detergent, and antimicrobial mechanisms (PMID: 34127070). Bile acids also act as detergents in the gut and support the absorption of fats through the intestinal membrane. These same properties allow for the disruption of bacterial membranes, thereby allowing them to serve a bacteriocidal or bacteriostatic function. In humans (and other mammals) bile acids are normally conjugated with the amino acids glycine and taurine by the liver. This conjugation catalyzed by two liver enzymes, bile acid CoA ligase (BAL) and bile acid CoA: amino acid N-acyltransferase (BAT). Glycine and taurine bound BAs are also referred to as bile salts due to their decreased pKa and complete ionization resulting in these compounds being present as anions in vivo. Unlike glycine and taurine-conjugated bile acids, these recently discovered bile acids, such as Cholylvaline, are produced by the gut microbiota, making them secondary bile acids (PMID: 32103176) or microbially conjugated bile acids (MCBAs) (PMID: 34127070). Evidence suggests that these bile acid-amino acid conjugates are produced by microbes belonging to Clostridia species (PMID: 32103176). These unusual bile acid-amino acid conjugates are found in higher frequency in patients with inflammatory bowel disease (IBD), cystic fibrosis (CF) and in infants (PMID: 32103176). Cholylvaline appears to act as an agonist for the farnesoid X receptor (FXR) and it can also lead to reduced expression of bile acid synthesis genes (PMID: 32103176). It currently appears that microbially conjugated bile acids (MCBAs) or amino acid-bile acid conjugates are only conjugated to cholic acid, deoxycholic acid and chenodeoxycholic acid (PMID: 34127070). It has been estimated that if microbial conjugation of bile acids is very promiscuous and occurs for all potential oxidized, epimerized, and dehydroxylated states of each hydroxyl group present on cholic acid (C3, C7, C12) in addition to ring orientation, the total number of potential human bile acid conjugates could be over 2800 (PMID: 34127070).

   

amphiasterin D2

amphiasterin D2

C29H49NO6 (507.356)


   
   

Valine conjugated cholic acid

Valine conjugated cholic acid

C29H49NO6 (507.356)


   

((4R)-4-((3R,5S,7R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoyl)valine

"((4R)-4-((3R,5S,7R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoyl)valine"

C29H49NO6 (507.356)


   

lysoDGTS 19:4

lysoDGTS 19:4

C29H49NO6 (507.356)


   

2-[[(E)-2-acetamido-3-hydroxyoctadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E)-2-acetamido-3-hydroxyoctadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C25H52N2O6P+ (507.3563)


   

2-[hydroxy-[(E)-3-hydroxy-2-(octanoylamino)dodec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-(octanoylamino)dodec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C25H52N2O6P+ (507.3563)


   

2-[[(E)-2-(dodecanoylamino)-3-hydroxyoct-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E)-2-(dodecanoylamino)-3-hydroxyoct-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C25H52N2O6P+ (507.3563)


   

2-[hydroxy-[(E)-3-hydroxy-2-(propanoylamino)heptadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-(propanoylamino)heptadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C25H52N2O6P+ (507.3563)


   

2-[hydroxy-[(E)-3-hydroxy-2-(pentanoylamino)pentadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-(pentanoylamino)pentadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C25H52N2O6P+ (507.3563)


   

2-[[(E)-2-(decanoylamino)-3-hydroxydec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E)-2-(decanoylamino)-3-hydroxydec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C25H52N2O6P+ (507.3563)


   

2-[hydroxy-[(E)-3-hydroxy-2-(nonanoylamino)undec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-(nonanoylamino)undec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C25H52N2O6P+ (507.3563)


   

2-[[(E)-2-(butanoylamino)-3-hydroxyhexadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E)-2-(butanoylamino)-3-hydroxyhexadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C25H52N2O6P+ (507.3563)


   

2-[[(E)-2-(heptanoylamino)-3-hydroxytridec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E)-2-(heptanoylamino)-3-hydroxytridec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C25H52N2O6P+ (507.3563)


   

2-[hydroxy-[(E)-3-hydroxy-2-(undecanoylamino)non-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-(undecanoylamino)non-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C25H52N2O6P+ (507.3563)


   

2-[[(E)-2-(hexanoylamino)-3-hydroxytetradec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E)-2-(hexanoylamino)-3-hydroxytetradec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C25H52N2O6P+ (507.3563)


   
   
   
   
   
   
   

Val-alphaMCA

Val-alphaMCA

C29H49NO6 (507.356)


   

Val-betaMCA

Val-betaMCA

C29H49NO6 (507.356)


   
   
   

ST 27:1;O4;Gly

ST 27:1;O4;Gly

C29H49NO6 (507.356)


   

ST 21:0;O;HexNAc

ST 21:0;O;HexNAc

C29H49NO6 (507.356)


   

(11z,13e)-6-{[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-16-ethyl-5,7,9,15-tetramethyl-1-oxacyclohexadeca-11,13-diene-2,10-dione

(11z,13e)-6-{[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-16-ethyl-5,7,9,15-tetramethyl-1-oxacyclohexadeca-11,13-diene-2,10-dione

C29H49NO6 (507.356)


   

methyl (2s)-1-{[(3r,4s,5r)-5-[(6e)-heptadec-6-en-1-yl]-4-hydroxy-5-methyl-2-oxooxolan-3-yl]methyl}-5-oxopyrrolidine-2-carboxylate

methyl (2s)-1-{[(3r,4s,5r)-5-[(6e)-heptadec-6-en-1-yl]-4-hydroxy-5-methyl-2-oxooxolan-3-yl]methyl}-5-oxopyrrolidine-2-carboxylate

C29H49NO6 (507.356)


   

methyl 1-{[5-(heptadec-6-en-1-yl)-4-hydroxy-5-methyl-2-oxooxolan-3-yl]methyl}-5-oxopyrrolidine-2-carboxylate

methyl 1-{[5-(heptadec-6-en-1-yl)-4-hydroxy-5-methyl-2-oxooxolan-3-yl]methyl}-5-oxopyrrolidine-2-carboxylate

C29H49NO6 (507.356)


   

methyl (2r)-1-{[(3s,4s,5r)-5-[(6e)-heptadec-6-en-1-yl]-4-hydroxy-5-methyl-2-oxooxolan-3-yl]methyl}-5-oxopyrrolidine-2-carboxylate

methyl (2r)-1-{[(3s,4s,5r)-5-[(6e)-heptadec-6-en-1-yl]-4-hydroxy-5-methyl-2-oxooxolan-3-yl]methyl}-5-oxopyrrolidine-2-carboxylate

C29H49NO6 (507.356)